About

Pascal Soriot has served as an Agilent director since May 2025 and is a member of the Compensation Committee. He has been Chief Executive Officer and an Executive Director of AstraZeneca PLC since October 2012, having previously served as Chief Operating Officer of Roche Pharma AG (2010-2012) and Chief Executive Officer of Genentech, Inc. (2009-2010). In 2022 he received a knighthood for services to life sciences and leadership in the global response to the COVID-19 pandemic.

Roles

Agilent Technologies, Inc.
Director · Current role
May 2025–present
Roche Pharma AG
Chief Operating Officer
January 2010 - August 2012
Genentech, Inc.
Chief Executive Officer · Until its merger with Roche
April 2009 - 2010

External Roles

AstraZeneca PLC
Chief Executive Officer and Executive Director
October 2012 - present
Sustainable Markets Initiative Limited
Director
April 2023 - present

Director Compensation

FY 2025
Cash retainer
$81,986
ComponentBoard and committee cash retainers earned in FY2025
Stock awards
$182,642
ComponentAnnual stock grant, ASC 718 grant-date fair value (1,819 shares)
Total
$264,628

Also at Agilent Technologies, Inc.

Colleague
Judy Gawlik Brown
Director
Colleague
Sue H. Rataj
Director
Colleague
George A. Scangos, Ph.D.
Director (Chair, Compensation Committee)

Related

Company
Agilent Technologies, Inc.
Company hub
Deal
Agilent Acea Biosciences 2018
Deal page
Deal
Agilent Advanced Analytical Aati 2018
Deal page

See how VectorShift works for your firm

Request Demo